Beom Joon Kim Selected Research

aluminum oxide hydroxide (boehmite)

1/2020	Boehmite enhances hair follicle growth via stimulation of dermal papilla cells by upregulating β-catenin signalling.
1/2019	Therapeutic potential of topically administered γ-AlOOH on 2,4-dinitrochlorobenzene-induced atopic dermatitis-like lesions in Balb/c mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beom Joon Kim Research Topics

Disease

55	Stroke (Strokes) 01/2022 - 01/2007
47	Ischemic Stroke 04/2022 - 05/2009
13	Alopecia (Baldness) 03/2022 - 05/2010
12	Neoplasms (Cancer) 01/2022 - 03/2009
10	Atrial Fibrillation 01/2022 - 12/2014
10	Cerebral Hemorrhage 01/2021 - 05/2009
10	Atopic Dermatitis (Atopic Eczema) 01/2020 - 06/2012
9	Acne Vulgaris 09/2022 - 01/2009
9	Cicatrix (Scar) 09/2022 - 08/2009
9	Erythema 12/2021 - 01/2008
8	Inflammation (Inflammations) 02/2022 - 04/2009
8	Alopecia Areata 12/2015 - 01/2008
7	Pain (Aches) 01/2021 - 01/2015
6	Hypertension (High Blood Pressure) 01/2022 - 09/2013
6	Infarction (Infarctions) 11/2021 - 10/2013
6	Melanosis (Freckles) 01/2018 - 08/2009
5	Wounds and Injuries (Trauma) 11/2021 - 05/2014
5	Atherosclerosis 11/2021 - 02/2014
5	Dermatitis 01/2021 - 10/2013
5	Hypertrophy 01/2021 - 08/2009
5	Hyperpigmentation 03/2020 - 03/2014
5	Melanoma (Melanoma, Malignant) 03/2020 - 01/2013
5	Atrophy 04/2019 - 03/2012
5	Rosacea (Acne Rosacea) 12/2018 - 01/2015
5	Skin Diseases (Skin Disease) 01/2016 - 08/2005
4	Hyperplasia 03/2022 - 01/2018
4	Embolic Stroke 11/2021 - 01/2017
4	Hematoma 01/2021 - 06/2013
4	Necrosis 11/2018 - 03/2017
4	Hemorrhage 05/2014 - 02/2011
3	Keloid 01/2022 - 12/2012
3	Cerebral Infarction 01/2022 - 01/2015
3	Granuloma 01/2022 - 12/2017
3	Myocardial Infarction 10/2021 - 12/2018
3	Diabetes Mellitus 01/2020 - 12/2014
3	Pathologic Constriction (Stenosis) 01/2020 - 01/2019
3	Transient Ischemic Attack 12/2018 - 01/2007
3	Cognitive Dysfunction 12/2017 - 03/2015
3	Pruritus (Itching) 09/2014 - 02/2011
3	Edema (Dropsy) 08/2014 - 07/2011
3	Allergic Contact Dermatitis 04/2014 - 06/2012
3	Dandruff 01/2012 - 03/2010
2	Hypertrophic Cicatrix (Hypertrophic Scar) 09/2022 - 05/2017
2	COVID-19 05/2022 - 04/2021
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 12/2014
2	Thrombosis (Thrombus) 11/2021 - 05/2009

Drug/Important Bio-Agent (IBA)

10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 02/2011
10	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 09/2015
7	Clopidogrel (Plavix)FDA Link 01/2022 - 10/2013
7	CytokinesIBA 08/2020 - 11/2012
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 07/2015
6	AnticoagulantsIBA 01/2021 - 04/2015
6	Melanins (Melanin)IBA 03/2020 - 01/2008
6	SteroidsIBA 01/2018 - 08/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2015
5	AntioxidantsIBA 03/2020 - 08/2010
4	Hemoglobins (Hemoglobin)IBA 01/2021 - 02/2010
4	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 01/2015
4	CholesterolIBA 01/2021 - 05/2009
4	Therapeutic UsesIBA 08/2020 - 08/2008
4	AcidsIBA 06/2019 - 12/2009
4	Type A Botulinum Toxins (Botox)FDA Link 04/2019 - 10/2014
4	Biomarkers (Surrogate Marker)IBA 12/2017 - 01/2012
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2015 - 12/2009
3	Finasteride (Propecia)FDA LinkGeneric 03/2022 - 11/2014
3	CollagenIBA 02/2022 - 01/2018
3	ORALIT (ORS)IBA 01/2022 - 12/2012
3	Dermal FillersIBA 11/2021 - 11/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 08/2010
3	TeaIBA 10/2018 - 06/2012
3	Immunoglobulin E (IgE)IBA 01/2018 - 11/2012
3	Epidermal Growth Factor (EGF)IBA 01/2018 - 08/2014
3	Pemetrexed (MTA)FDA Link 12/2017 - 03/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2017 - 06/2012
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2015 - 01/2008
3	Carbon DioxideIBA 11/2014 - 12/2009
2	Triglycerides (Triacylglycerol)IBA 04/2022 - 09/2010
2	Hemostatics (Antihemorrhagics)IBA 01/2022 - 01/2021
2	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 01/2013
2	Cytidine Triphosphate (CTP)IBA 01/2022 - 08/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2021 - 02/2010
2	Biological ProductsIBA 07/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2007
2	evening primrose oilIBA 01/2021 - 12/2014
2	Saline SolutionIBA 01/2021 - 08/2019
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2021 - 12/2020

Therapy/Procedure

37	Therapeutics 12/2021 - 01/2008
22	Lasers (Laser) 09/2022 - 08/2009
10	Thrombectomy 01/2022 - 01/2017
7	Solid-State Lasers 01/2018 - 12/2009
7	Photochemotherapy (Photodynamic Therapy) 01/2015 - 01/2009
6	Injections 12/2020 - 08/2014
4	Gas Lasers 11/2021 - 07/2014
4	Aftercare (After-Treatment) 12/2020 - 05/2014
4	Phototherapy (Light Therapy) 08/2020 - 06/2012
3	Punctures 01/2022 - 01/2020
3	Stents 04/2021 - 11/2015
3	Dye Lasers 11/2018 - 08/2009
3	Tattooing 12/2017 - 08/2011
2	Microspheres (Microsphere) 02/2022 - 06/2019